Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

XENE

Xenon Pharmaceuticals Inc

Dec 13 • 04:00PM ET

40.05

Dollar change +0.60
Percentage change 1.52	%

Healthcare • Biotechnology • Canada • NASD

Peers: CRSP BGNE ARGX ARWR AKRO EDIT ACAD AGEN KURA ARDX

| Held by: IBB VHT SPDW ESML SBIO VT SMMV FHLC ONEQ MSSM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.81	Insider Own	3.86%	Shs Outstand	75.79M	Perf Week	-6.25%
Market Cap	3.10B	Forward P/E	-	EPS next Y	-3.60	Insider Trans	-0.17%	Shs Float	73.30M	Perf Month	-4.57%
Income	-213.39M	PEG	-	EPS next Q	-0.85	Inst Own	95.33%	Short Float	3.93%	Perf Quarter	0.18%
Sales	0.00M	P/S	-	EPS this Y	-12.97%	Inst Trans	1.04%	Short Ratio	7.80	Perf Half Y	7.52%
Book/sh	10.53	P/B	3.80	EPS next Y	-16.67%	ROA	-28.32%	Short Interest	2.88M	Perf Year	0.38%
Cash/sh	8.45	P/C	4.74	EPS next 5Y	8.90%	ROE	-29.75%	52W Range	35.53 - 50.99	Perf YTD	-13.05%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-10.87%	ROI	-26.47%	52W High	-21.46%	Beta	1.19
Dividend TTM	-	Quick Ratio	22.21	Sales past 5Y	35.90%	Gross Margin	-	52W Low	12.72%	ATR (14)	1.62
Dividend Ex-Date	-	Current Ratio	22.21	EPS Y/Y TTM	-5.62%	Oper. Margin	-	RSI (14)	43.35	Volatility	4.71% 3.95%
Employees	259	Debt/Eq	0.01	Sales Y/Y TTM	-100.00%	Profit Margin	-	Recom	1.12	Target Price	57.18
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-9.75%	Payout	-	Rel Volume	1.15	Prev Close	39.45
Sales Surprise	-	EPS Surprise	0.69%	Sales Q/Q	-	Earnings	Nov 12 AMC	Avg Volume	369.20K	Price	40.05
SMA20	-2.81%	SMA50	-4.33%	SMA200	-2.33%	Trades		Volume	424,118	Change	1.52%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-10-24	Resumed	Raymond James	Outperform	$50
Oct-01-24	Initiated	H.C. Wainwright	Buy	$53
Jan-04-24	Initiated	Citigroup	Buy	$62
Dec-08-23	Initiated	Robert W. Baird	Outperform	$63
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight
Apr-25-23	Initiated	Cantor Fitzgerald	Overweight	$58
Dec-14-22	Initiated	Goldman	Buy	$60
Dec-12-22	Initiated	Cowen	Outperform
Nov-28-22	Initiated	Wells Fargo	Overweight	$50
Oct-19-22	Initiated	Raymond James	Outperform	$52
Aug-29-22	Initiated	BofA Securities	Buy	$45
Jul-21-22	Initiated	JP Morgan	Overweight	$55
Oct-28-21	Initiated	RBC Capital Mkts	Outperform	$43
Oct-02-20	Initiated	SVB Leerink	Outperform	$22
Jul-21-20	Initiated	Needham	Buy	$22
Jun-01-20	Resumed	Jefferies	Buy	$23
Mar-25-20	Initiated	Wedbush	Outperform	$23
Jan-08-20	Initiated	William Blair	Outperform
Sep-20-19	Initiated	Guggenheim	Buy	$25
Aug-08-18	Reiterated	Stifel	Buy	$9 → $15

Show Previous Ratings

Dec-12-24 11:30AM	Xenon Pharmaceuticals (XENE) Up 2.4% Since Last Earnings Report: Can It Continue? (Zacks) -8.19%
Dec-06-24 04:01PM	Xenon Showcases New Long-Term Azetukalner Data from X-TOLE OLE Study in FOS at AES 2024 (GlobeNewswire)
Nov-25-24 08:30AM	Xenon to Showcase New Long-Term Azetukalner Data at AES 2024 (GlobeNewswire)
Nov-22-24 09:30AM	JPMorgan Selects These 2 Stocks as Must-Haves for 2025 (TipRanks)
Nov-13-24 04:01PM	Xenon to Present at Upcoming Investor Conferences (GlobeNewswire)
02:17AM	Loading…
02:17AM	Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ... (GuruFocus.com)
Nov-12-24 04:07PM	Xenon Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports Q3 2024 Financial Results and Business Update (GlobeNewswire)
Nov-11-24 07:06AM	Earnings To Watch: Xenon Pharmaceuticals Inc (XENE) Reports Q3 2024 Result (GuruFocus.com)
Nov-05-24 04:01PM	Xenon to Report Q3 2024 Financial Results on November 12, 2024 (GlobeNewswire)
Oct-09-24 05:54PM	Xenon Pharmaceuticals Inc (XENE) Q2 2024 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Oct-02-24 04:28PM	Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference (GlobeNewswire)
Sep-09-24 08:30AM	Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress (GlobeNewswire)
Sep-05-24 01:12AM	Xenon Pharmaceuticals Inc. (XENE): Among the Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
Sep-02-24 06:05PM	10 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
10:46AM	Loading…
Aug-21-24 10:46AM	Xenon (XENE) Focuses on Neuro Candidate Amid Pipeline Woe (Zacks)
Aug-12-24 08:30AM	Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer (GlobeNewswire)
Aug-09-24 10:19AM	Xenon (XENE) Q2 Earnings Miss, Pipeline in Focus, Stock Down (Zacks)
Aug-08-24 09:59PM	XENE Stock Earnings: Xenon Pharmaceuticals Misses EPS for Q2 2024 (InvestorPlace)
04:26PM	Xenon Pharmaceuticals: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports Q2 2024 Financial Results and Business Update (GlobeNewswire)
Aug-01-24 04:01PM	Xenon to Report Q2 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jun-27-24 03:54PM	Is Xenon Pharmaceuticals Inc. (XENE) One of the Best Healthcare Stocks Under $50? (Insider Monkey)
Jun-05-24 04:01PM	Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (GlobeNewswire)
May-28-24 08:30AM	Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting (GlobeNewswire)
May-27-24 06:55PM	Hedge Funds are Racking Up Shares of This Healthcare Stock (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
May-10-24 05:03PM	Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:56PM	Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ... (GuruFocus.com)
08:17AM	Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus (Zacks)
07:29AM	Loading…
07:29AM	Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating (MT Newswires)
May-09-24 08:57PM	XENE Stock Earnings: Xenon Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace)
04:29PM	Xenon Pharmaceuticals Q1 Net Loss Narrows (MT Newswires)
04:17PM	Xenon Pharmaceuticals: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-08-24 04:01PM	Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024 (GlobeNewswire)
May-07-24 04:01PM	Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-06-24 12:00PM	What Makes Xenon Pharmaceuticals (XENE) a New Buy Stock (Zacks)
May-02-24 04:01PM	Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update (GlobeNewswire)
Apr-16-24 08:30AM	Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
Apr-10-24 08:30AM	Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference (GlobeNewswire)
Apr-04-24 04:01PM	Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-12-24 04:01PM	Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days (GlobeNewswire)
Mar-08-24 11:55PM	Insider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ... (GuruFocus.com)
Mar-05-24 04:01PM	Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 (GlobeNewswire)
Mar-02-24 08:37AM	Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 08:35AM	Xenon (XENE) Q4 Earnings Top Estimates, Pipeline in Focus (Zacks)
Feb-29-24 04:34PM	Xenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Results (GuruFocus.com)
04:13PM	Xenon Pharmaceuticals: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-22-24 04:01PM	Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Feb-21-24 10:08PM	3 Biotech Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
Jan-23-24 08:36AM	Here's Why You Should Add Xenon (XENE) to Your Portfolio Now (Zacks)
Jan-19-24 09:55AM	Wall Street Analysts Think Xenon Pharmaceuticals (XENE) Could Surge 25.76%: Read This Before Placing a Bet (Zacks)
Jan-08-24 08:00AM	Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 (GlobeNewswire) +5.23%
Jan-03-24 08:30AM	Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-05-23 01:31PM	5 Most Promising Stocks to Buy According to Hedge Funds (Insider Monkey)
Dec-04-23 04:16PM	Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Dec-02-23 12:01PM	Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) (GlobeNewswire)
Nov-29-23 10:51PM	Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering (GlobeNewswire) +8.39%
04:03PM	Xenon Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire)
Nov-28-23 11:17AM	Xenon (XENE) Up on Top-Line Data From MDD Drug Phase II Study (Zacks)
Nov-27-23 04:28PM	The Unexpected Depression Drug News That Sent Xenon Pharmaceuticals Soaring (Investor's Business Daily) +17.78%
12:19PM	Cerence, Roivant Sciences fall; Xenon Pharmaceuticals, Shopify rise, Monday, 11/27/2023 (Associated Press Finance)
07:30AM	UPDATE 1-Canada's Xenon Pharma's depression drug fails to meet main goal in study (Reuters)
07:09AM	Xenon Pharmaceuticals' depression drug fails to meet main goal in study (Reuters)
07:00AM	Xenon Pharmaceuticals Announces Topline Results from Phase 2 Proof-of-Concept X-NOVA Clinical Trial of XEN1101 in Major Depressive Disorder (MDD) (GlobeNewswire)
04:21AM	Xenon drug misses main goal of depression study (BioPharma Dive)
Nov-09-23 05:14PM	Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2023 Earnings Call Transcript (Insider Monkey) -6.69%
04:03PM	Xenon Pharmaceuticals Provides Update on Partnered Program with Neurocrine Biosciences (GlobeNewswire)
Nov-08-23 04:28PM	Xenon Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:01PM	Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire) +5.93%
Oct-31-23 02:58AM	13 Best Canadian Stocks to Buy and Hold (Insider Monkey)
Oct-09-23 04:15PM	Xenon Pharmaceuticals Announces Publication of Results from XEN1101 Phase 2b X-TOLE Clinical Trial in Peer-Reviewed Journal Article in JAMA Neurology (GlobeNewswire)
Oct-06-23 08:30AM	Xenon Pharmaceuticals to Present at Jefferies Inaugural Biotech CNS/Neuro Summit (GlobeNewswire)
Sep-14-23 04:01PM	Xenon Pharmaceuticals to Present at TD Cowens 3rd Annual Novel Mechanisms in Neuropsychiatry Summit (GlobeNewswire)
Sep-12-23 04:30PM	Xenon Pharmaceuticals Announces Upcoming Investor Webinar with Leading Key Opinion Leaders to Discuss XEN1101 and Major Depressive Disorder (GlobeNewswire)
Sep-04-23 08:30AM	Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at 35th International Epilepsy Congress (GlobeNewswire)
Aug-31-23 10:16PM	12 Best High Risk High Reward Stocks To Buy Now (Insider Monkey)
04:01PM	Xenon Pharmaceuticals to Present at the Wells Fargo 2023 Healthcare Conference (GlobeNewswire)
Aug-29-23 10:21AM	Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks (TipRanks)
Aug-11-23 09:55AM	Wall Street Analysts Believe Xenon Pharmaceuticals (XENE) Could Rally 36.75%: Here's is How to Trade (Zacks)
Aug-09-23 05:15PM	Xenon Pharmaceuticals (XENE) Reports Q2 Loss, Misses Revenue Estimates (Zacks) +8.29%
04:09PM	Xenon Pharmaceuticals: Q2 Earnings Snapshot (AP Finance)
04:01PM	Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
08:03AM	Companies Like Xenon Pharmaceuticals (NASDAQ:XENE) Are In A Position To Invest In Growth (Simply Wall St.)
Aug-08-23 04:01PM	Xenon Pharmaceuticals Expands Leadership on its Board of Directors with Appointments of Gillian M. Cannon and Justin Gover (GlobeNewswire)
Aug-02-23 04:01PM	Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Second Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)
Jul-23-23 11:44AM	11 Best Healthcare Stocks Under $50 (Insider Monkey)
Jun-06-23 04:35PM	Xenon Pharmaceuticals to Present at the Goldman Sachs 44th Annual Global Healthcare Conference (GlobeNewswire)
May-31-23 04:01PM	Xenon Pharmaceuticals to Present at the 2023 Jefferies Healthcare Conference (GlobeNewswire)
May-11-23 04:01PM	Xenon Pharmaceuticals to Present at the 2023 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-09-23 05:15PM	Xenon Pharmaceuticals (XENE) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -5.51%
04:13PM	Xenon Pharmaceuticals: Q1 Earnings Snapshot (AP Finance)
04:01PM	Xenon Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
May-04-23 10:00AM	Earnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline (Zacks)
03:52AM	Sutro Biopharma, Inc. (STRO) Soars 11.3%: Is Further Upside Left in the Stock? (Zacks)
May-03-23 04:01PM	Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2023 (GlobeNewswire)
May-02-23 04:01PM	Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update (GlobeNewswire)

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PATOU GARY	Director	Nov 22 '24	Option Exercise	10.24	6,586	67,429	27,073	Nov 22 07:48 PM
PATOU GARY	Director	Nov 22 '24	Sale	41.08	4,891	200,947	23,573	Nov 22 07:48 PM
GARY PATOU	Director	Nov 22 '24	Proposed Sale	41.08	4,891	200,932		Nov 22 06:55 PM
GAROFALO ELIZABETH A.	Director	Mar 08 '24	Option Exercise	18.56	3,500	64,960	3,500	Mar 11 08:09 PM
GAROFALO ELIZABETH A.	Director	Mar 08 '24	Sale	45.69	2,092	95,583	0	Mar 11 08:09 PM
ROBIN SHERRINGTON	EVP, Strategy & Innovation	Mar 07 '24	Option Exercise	9.85	8,641	85,114	16,824	Mar 08 05:31 PM
ROBIN SHERRINGTON	EVP, Strategy & Innovation	Mar 07 '24	Sale	46.28	7,137	330,290	8,398	Mar 08 05:31 PM
GANNON STEVEN	Director	Mar 07 '24	Sale	46.28	13,000	601,615	2,000	Mar 08 05:28 PM
AZAB MOHAMMAD	Director	Dec 19 '23	Option Exercise	9.85	4,320	42,552	74,225	Dec 20 05:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XENE

Xenon Pharmaceuticals Inc

Upgrade your FINVIZ experience